{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:56:23Z","timestamp":1790834183104,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:00:00Z","timestamp":1343260800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00296-012-2466-5","type":"journal-article","created":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T10:26:12Z","timestamp":1343211972000},"page":"1047-1052","source":"Crossref","is-referenced-by-count":19,"title":["Prospective, open-label, uncontrolled pilot study to study safety and efficacy of sildenafil in systemic sclerosis\u2013related pulmonary artery hypertension and cutaneous vascular complications"],"prefix":"10.1007","volume":"33","author":[{"given":"Uma","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sankalp S.","family":"Gokhle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Sreenivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satbir","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durgaprasanna","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"key":"2466_CR1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ncprheum0115","volume":"2","author":"CP Denton","year":"2009","unstructured":"Denton CP, Black CM, Abraham DJ (2009) Mechanism and consequence of fibrosis in systemic sclerosis. Nat Clin Pract Rheumatol 2:134\u2013144","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"1","key":"2466_CR2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/art.21538","volume":"54","author":"S Trad","year":"2006","unstructured":"Trad S, Amoura Z, Beigelman C et al (2006) Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis independent of interstitial lung disease. Arthritis Rheum 54(1):184\u2013191","journal-title":"Arthritis Rheum"},{"issue":"8","key":"2466_CR3","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/art.10442","volume":"46","author":"M Magliano","year":"2002","unstructured":"Magliano M, Isenberg DA, Hillson J (2002) Pulmonary hypertension in autoimmune rheumatic diseases: where are we now? Arthritis Rheum 46(8):1997\u20132009","journal-title":"Arthritis Rheum"},{"key":"2466_CR4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1378\/chest.123.2.344","volume":"123","author":"SM Kawut","year":"2003","unstructured":"Kawut SM, Taichman DB, Archer-Chicko CL (2003) Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 123:344\u2013350","journal-title":"Chest"},{"issue":"5","key":"2466_CR5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1067\/mcp.2002.123554","volume":"71","author":"H Watanabe","year":"2002","unstructured":"Watanabe H, Ohashi K, Takeuchi K et al (2002) Sildenafil for primary and secondary pulmonary hypertension. Clin Pharmacol Ther 71(5):398\u2013402","journal-title":"Clin Pharmacol Ther"},{"issue":"20","key":"2466_CR6","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","volume":"353","author":"N Gali\u00e8","year":"2005","unstructured":"Gali\u00e8 N, Ghofrani HA, Torbicki A et al (2005) Sildenafil use in pulmonary arterial hypertension (SUPER) Study Group. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 353(20):2148\u20132157","journal-title":"N Engl J Med"},{"issue":"11","key":"2466_CR7","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1164\/rccm.200410-1411OC","volume":"171","author":"MR Wilkins","year":"2005","unstructured":"Wilkins MR, Paul GA, Strange JW et al (2005) Sildenafil versus endothelin receptor antagonist for pulmonary hypertension (SERAPH) study. Am J Respir Crit Care Med 171(11):1292\u20131297","journal-title":"Am J Respir Crit Care Med"},{"issue":"14","key":"2466_CR8","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/CIRCULATIONAHA.107.716373","volume":"116","author":"GD Lewis","year":"2007","unstructured":"Lewis GD, Shah R, Shahzad K et al (2007) Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation 116(14):1555\u20131562","journal-title":"Circulation"},{"issue":"12","key":"2466_CR9","first-page":"2417","volume":"34","author":"DB Badesch","year":"2007","unstructured":"Badesch DB, Hill NS, Burgess G, SUPER Study Group et al (2007) Sildenafil for pulmonary arterial hypertension associated with connective tissue disease. J Rheumatol 34(12):2417\u20132422","journal-title":"J Rheumatol"},{"issue":"10","key":"2466_CR10","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/hr.2009.113","volume":"32","author":"XQ Xu","year":"2009","unstructured":"Xu XQ, Jing ZC, Zhang JH et al (2009) The efficacy and safety of sildenafil in Chinese patients with pulmonary arterial hypertension. Hypertens Res 32(10):911\u2013915","journal-title":"Hypertens Res"},{"issue":"3","key":"2466_CR11","first-page":"799","volume":"33","author":"M Samarzija","year":"2009","unstructured":"Samarzija M, Zuljevi\u00c4 E, Jakopovi\u00c4 M et al (2009) One year efficacy and safety of oral sildenafil treatment in severe pulmonary hypertension. Coll Antropol 33(3):799\u2013803","journal-title":"Coll Antropol"},{"issue":"7\u20138","key":"2466_CR12","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1345\/aph.1H005","volume":"40","author":"TL Levien","year":"2006","unstructured":"Levien TL (2006) Phosphodiesterase inhibitors in Raynaud\u2019s phenomenon. Ann Pharmacother 40(7\u20138):1388\u20131393","journal-title":"Ann Pharmacother"},{"issue":"2","key":"2466_CR13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/oem.54.2.90","volume":"54","author":"G Gemne","year":"1997","unstructured":"Gemne G (1997) Diagnostics of hand-arm system disorders in workers who use vibrating tools. Occup Environ Med 54(2):90\u201395","journal-title":"Occup Environ Med"},{"key":"2466_CR14","first-page":"410","volume":"54","author":"BK Sastry","year":"2002","unstructured":"Sastry BK, Narasimhan C, Reddy NK et al (2002) Study of clinical efficacy of sildenafil in patients with primary pulmonary hypertension. Indian Heart J 54:410\u2013414","journal-title":"Indian Heart J"},{"issue":"4","key":"2466_CR15","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ahj.2005.09.006","volume":"151","author":"TP Singh","year":"2006","unstructured":"Singh TP, Rohit M, Grover A (2006) A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension. Am Heart J 151(4):851\u2013855","journal-title":"Am Heart J"},{"issue":"3","key":"2466_CR16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ijcard.2006.10.017","volume":"120","author":"N Garg","year":"2007","unstructured":"Garg N, Sharma MK, Sinha N (2007) Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship. Int J Cardiol 120(3):306\u2013313","journal-title":"Int J Cardiol"},{"issue":"15","key":"2466_CR17","first-page":"1021","volume":"87","author":"TG Kuang","year":"2007","unstructured":"Kuang TG, Wang J, Zhai ZG (2007) Efficacy and safety of sildenafil therapy in pulmonary artery hypertension: a meta-analysis. Zhonghua Yi Xue Za Zhi 87(15):1021\u20131024","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"2466_CR18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1164\/ajrccm.161.2.9906015","volume":"161","author":"S Miyamoto","year":"2000","unstructured":"Miyamoto S, Nagaya N, Satoh T et al (2000) Clinical correlates and prognostic significance of six minutes\u2019 walk test in patients with primary pulmonary hypertension. Am J Respir Crit Care Med 161:487\u2013492","journal-title":"Am J Respir Crit Care Med"},{"key":"2466_CR19","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1161\/CIRCULATIONAHA.104.523324","volume":"112","author":"R Fries","year":"2005","unstructured":"Fries R, Shariat K, von Wilmowsky H et al (2005) Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy. Circulation 112:2980\u20132985","journal-title":"Circulation"},{"issue":"3","key":"2466_CR20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00105-007-1366-1","volume":"59","author":"E Friedrichson","year":"2008","unstructured":"Friedrichson E, Rehberger P, Fuhrmann JT et al (2008) Fast and efficient healing of scleroderma-associated acral ulcers with sildenafil. Hautarzt 59(3):230\u2013232","journal-title":"Hautarzt"},{"issue":"5A","key":"2466_CR21","doi-asserted-by":"crossref","first-page":"13C","DOI":"10.1016\/S0002-9149(99)00043-0","volume":"83","author":"G Jackson","year":"1999","unstructured":"Jackson G, Benjamin N, Jackson N et al (1999) Effect of sildenafil citrate on human hemodynamics. Am J Cardiol 83(5A):13C\u201320C","journal-title":"Am J Cardiol"},{"key":"2466_CR22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1067\/mcp.2002.123554","volume":"71","author":"H Watanabe","year":"2002","unstructured":"Watanabe H, Ohashi K, Takeuchi K et al (2002) Sildenafil for primary and secondary pulmonary hypertension. Clin Pharmacol Ther 71:398\u2013402","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"2466_CR23","doi-asserted-by":"crossref","first-page":"871","DOI":"10.7326\/0003-4819-139-10-200311180-00030","volume":"134","author":"S Rosenkranz","year":"2003","unstructured":"Rosenkranz S, Diet F, Karasch T et al (2003) Sildenafil improved pulmonary hypertension and peripheral blood flow in a patient with scleroderma-associated lung fibrosis and the raynaud phenomenon. Ann Intern Med 134(10):871\u2013872","journal-title":"Ann Intern Med"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2466-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-012-2466-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2466-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T17:13:36Z","timestamp":1562001216000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-012-2466-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,26]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["2466"],"URL":"https:\/\/doi.org\/10.1007\/s00296-012-2466-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,26]]}}}